SOLAIRIA-1 AND SOLAIRIA-2 Phase 3 studies for GB-0895 (anti-TSLP) in severe asthma continue to advance with recruitment underway across all six global regions Phase 1b data for GB-0895 in COPD to be ...

The Preliminary Report of the Independent International Scientific Panel on AI: Evidence-based assessment of opportunities, risks and impacts of AI is a first-of-its-kind independent scientific ...

Some US police departments seem to be adopting AI-assisted police report products despite the technology’s deal-breaking civil liberties problems, some of which ...

(TNS) — Connecticut prosecutors and police chiefs have put the brakes on the rapidly expanding acquisition by police agencies of artificial intelligence-powered law enforcement tools until the ...

Multiple Chinese online platforms are openly selling tutorials on how to use AI to generate pornographic videos. For as little as 9.9 yuan ($1.4), users can purchase prompts to feed chatbots and ...

The vast data centers that power artificial intelligence guzzle huge amounts of energy but they also have another alarming impact, according to new research. They are creating “heat islands,” warming ...

With Claude enjoying a moment of newfound popularity among regular people, Anthropic is previewing an update designed to make its chatbot better at explaining some concepts. Starting today, Claude can ...

Claude will automatically generate interactive visuals based on your conversation, or you can ask it directly, too. Claude will automatically generate interactive visuals based on your conversation, ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Generate Biomedicines Inc. raised $400 million in an initial public offering, pricing its shares at the midpoint of the marketed range. The Somerville, Massachusetts-based drug developer sold 25 ...

Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...

Seedance 2.0 can take camera movement, visual effects, and motion into account. Seedance 2.0 can take camera movement, visual effects, and motion into account. is a news writer who covers the ...